Mechanism of Action

• Rabeprazole: Suppresses gastric acid secretion by inhibiting the ATPase pump in stomach lining
• Levosulpiride: Enhances gastrointestinal motility and accelerates gastric emptying by acting as a dopamine antagonist

This dual action provides both acid control and symptom relief.

Indications

• Gastroesophageal Reflux Disease (GERD)
• Acid reflux & heartburn
• Functional dyspepsia
• Gastritis
• Bloating, nausea & early satiety

Key Benefits

• Provides rapid and long-lasting acid suppression
• Improves gastric motility and digestion
• Reduces bloating, discomfort, and nausea
• Enhances patient compliance with dual-action therapy

Dosage & Administration

• Usually once daily before meals, or as directed by a physician
• Capsule should be swallowed whole (do not crush or chew)

Packaging

• 10 x 10 Capsules (Blister Pack)

Precautions

• Use cautiously in patients with liver or kidney disorders
• Long-term use should be monitored for vitamin B12 deficiency
• Avoid alcohol during treatment
• Not recommended without medical supervision

Possible Side Effects

• Headache
• Diarrhea or constipation
• Dizziness
• Mild abdominal discomfort

Why Choose Okareb-L

• Dual mechanism for superior GERD management
• Combines acid control + motility improvement
• Widely prescribed in gastroenterology practice
• High demand in PCD pharma and general medicine segment

Conclusion

Rabeprazole + Levosulpiride capsules offer a comprehensive solution for acid-related disorders, addressing both excess acid production and impaired gastric motility, leading to faster and sustained symptom relief.